Purpose | Board Meetings Date | Announcement Date |
---|---|---|
Board Meeting | 23 May 2025 | 15 May 2025 |
Sharma East India Hospitals & Medical Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2025 inter alia to consider and approve 1. To consider and approve the Standalone Audited Financial Results along with Auditor Report for the year ended March 31 2025 pursuant to regulation 33 of SEBI (LODR) Regulation 2015. 2. Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director. This is to inform you that the Board of Directors of SHARMA EAST INDIA HOSPITALS AND MEDICAL RESEARCH LTD in their meeting held on today i.e., Friday the 23rd May 2025 at the registered office of the Company at 4.00 p.m. (IST) and concluded at 9.30 p.m. (IST) approved following: 1. IND-AS compliant Standalone Audited Financial Results along with Declaration and Auditors Report for the quarter and year ended on 31st March, 2025 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. IND-AS compliant Standalone statement of Assets and Liabilities for the year ended 31st March, 2025. 3. Cash flow Standalone statement for the year ended March 31, 2025. 4. Declaration with respect to audit report with unmodified opinion for the financial year ended on March 31, 2025. (As Per BSE Announcement Dated on :23.05.2025) | ||
Board Meeting | 9 May 2025 | 9 May 2025 |
Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we hereby inform you that that the Board of Directors of the Company, at their meeting held on Friday, 9th May 2025, has pursuant to the recommendations of the Audit Committee, inter alia, considered and approved the following. 1. Appointment of M/s. Jain Vaibhav & Associates, Chartered Accountants, as the Internal Auditor of the Company for FY 2025-26. 2. Appointment of M/s. HSPN & Associates LLP, Practising Company Secretary as the Secretarial auditor of the Company for the FY 2025-2026. | ||
Board Meeting | 10 Jan 2025 | 3 Jan 2025 |
SHARMA EAST INDIA HOSPITALS & MEDICAL RESEARCH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/01/2025 inter alia to consider and approve 1. To approve IND-AS compliant Standalone Un-audited Financial Results along with Limited Review Report for the quarter ended on 31st December 2024 pursuant to Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015. 2. Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director. We would like to inform you that the Board of Directors at their Meeting held today i.e. Friday, 10th January, 2025 inter-alia considered and approved the Un-audited Financial Results along with Limited Review Report for the quarter ended 31st December, 2024 Un-audited Financial Results along with Limited Review Report for the quarter ended 31st December, 2024. (As per BSE Announcement Dated on 10/01/2025) As per Attachments (As per BSE Announcement Dated on 03/03/2025) | ||
Board Meeting | 14 Nov 2024 | 9 Nov 2024 |
SHARMA EAST INDIA HOSPITALS & MEDICAL RESEARCH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve This is to inform you that the meeting of the Board of Directors of Sharma East India Hospitals & Research Limited is scheduled to be held on Thursday 14th November 2024. Un-audited Financial Results along with Limited Review Report for the quarter ended 30th September, 2024. (As per BSE Announcement dated on 14/11/2024) | ||
Board Meeting | 6 Sep 2024 | 3 Sep 2024 |
SHARMA EAST INDIA HOSPITALS & MEDICAL RESEARCH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/09/2024 inter alia to consider and approve Pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that a meeting of the Board of Directors of Sharma East India Hospitals & Medical Research Limited (Company) is scheduled to be held on Friday 6th September 2024. Please find attached herewith Outcome of Board Meeting Held on 06th September, 2024. (As per BSE Announcement dated on 06/09/2024) | ||
Board Meeting | 13 Aug 2024 | 6 Aug 2024 |
SHARMA EAST INDIA HOSPITALS & MEDICAL RESEARCH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve 1. To approve IND-AS compliant Standalone Un-audited Financial Results along with Limited Review Report for the quarter ended on 30th June 2024 pursuant to regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015. 2. Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director. approval of unaudited financial results for the quarter ended 30-06-2024 (As Per Bse Announcement Dated on 13.08.2024) | ||
Board Meeting | 25 Jul 2024 | 22 Jul 2024 |
SHARMA EAST INDIA HOSPITALS & MEDICAL RESEARCH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2024 inter alia to consider and approve as per attachment. Outcome of Board Meeting as per attachment. (As Per BSE Announcement dated on 25.07.2024) |
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.